Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: A randomized, double-blind study

Journal of ECT

Volumn 30, Issue 1, 2014, Pages 15-21

  Yoosefi, Abolghasem ^a   Sepehri, Amir Sasan ^b   Kargar, Mona ^c   Akhondzadeh, Shahin ^d   Sadeghi, Majid ^d   Rafei, Ali ^e   Alimadadi, Abbas ^f   Ghaeli, Padideh ^g  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Faculty of Pharmacy   (Canada)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f University of Applied Science and Technology   (Iran)

^g TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

depressive disorder; ECT; electroconvulsive therapy; HAM D; Hamilton Depression Rating Scale; ketamine; thiopental

Indexed keywords

KETAMINE; THIOPENTAL;

ADULT; BLOOD PRESSURE; CLINICAL ARTICLE; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ELECTRICITY; ELECTROCONVULSIVE THERAPY; FEMALE; HAMILTON SCALE; HEART RATE; HUMAN; MAJOR DEPRESSION; MALE; MINI MENTAL STATE EXAMINATION; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANALYSIS OF VARIANCE; ANESTHESIA; ANESTHETICS, DISSOCIATIVE; COGNITION; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; ELECTROCONVULSIVE THERAPY; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; KETAMINE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; RECOVERY OF FUNCTION; SEIZURES; THIOPENTAL; YOUNG ADULT;

EID: 84894477738     PISSN: 10950680     EISSN: 15334112     Source Type: Journal    
DOI: 10.1097/YCT.0b013e3182a4b4c6     Document Type: Article

References (38)

1. Garcia LSB, Comim CM, Valvassori SS, et al. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32:140-144.
2. Machado-Vieira R, Salvadore G, DiazGranados N, et al. Ketamine and the next generation of antidepressants with a rapid onset of action. Pharmacol Ther. 2009;123:143-150.
3. Robson MJ, Elliott M, Seminerio MJ, et al. Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. Eur Neuropsychopharmacol. 2012;22:308-317.
4. Merkl A, Heuser I, Bajbouj M. Antidepressant electroconvulsive therapy: mechanism of action, recent advances and limitations. Exp Neurol. 2009;219:20-26.
5. Ibrahim L, Diazgranados N, Luckenbaugh DA, et al. Rapid decrease in depressive symptoms with an N-methyl-D-aspartate antagonist in ECT-resistant major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:1155-1159.
6. Gregory-Roberts EM, Naismith SL, Cullen KM, et al. Electroconvulsive therapy-induced persistent retrograde amnesia: could it be minimised by ketamine or other pharmacological approaches? J Affect Disord. 2010;126:39-45.
7. Hooten WM, Rasmussen KGJ. Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review. J ECT. 2008;24:208-223.
8. Calarge CA, Crowe RR, Gergis SD, et al. The comparative effects of sevoflurane and methohexital for electroconvulsive therapy. J ECT. 2003;19:221-225.
9. Pigot MB, Andrade C, Franzcp CL. Pharmacological attenuation of electroconvulsive therapy-induced cognitive deficits: theoretical background and clinical findings. J ECT. 2008;24:57-67.
10. MacPherson RD, Loo CK. Cognitive impairment following electroconvulsive therapy-does the choice of anesthetic agent make a difference? J ECT. 2008;24:52-56.
11. McDaniel WW, Sahota AK, Vyas BV, et al. Ketamine appears associated with better word recall than etomidate after a course of 6 electroconvulsive therapies. J ECT. 2006;22:103-106.
12. Copeland J, Dillon P. The health and psycho-social consequences of ketamine use. Int J Drug Policy. 2005;16:122-131.
13. Okamoto N, Nakai T, Sakamoto K, et al. Rapid antidepressant effect of ketamine anesthesia during electroconvulsive therapy of treatment-resistant depression: comparing ketamine and propofol anesthesia. J ECT. 2010;26:223-227.
14. Krystal AD, Weiner RD, Dean MD, et al. Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT. J Neuropsychiatry Clin Neurosci. 2003;15:27-34.
15. Brun VH, Ytterbø K, Morris RGM, et al. Retrograde amnesia for spatial memory induced by NMDA receptor-mediated long-term potentiation. J Neurosci. 2001;21:356-362.
16. Hashimoto K. Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions. Psychiatry Clin Neurosci. 2010;64:341-357.
17. Engin E, Treit D, Dickson CT. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models. Neuroscience. 2009;161:359-369.
18. Goforth HW, Holsinger T. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy. J ECT. 2007;23:23-25.
19. Rot M, Collins KA, Murrough JW, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2010;67:139-145.
20. Datto C, Rai AK, Ilivicky HJ, et al. Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal. J ECT. 2002; 18:118-125.
21. Geretsegger C, Nickel M, Judendorfer B, et al. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. J ECT. 2007;23:239-243.
22. Schmittner MD, Vajkoczy SL, Horn P, et al. Effects of fentanyl and S(+)-ketamine on cerebral hemodynamics, gastrointestinal motility, and need of vasopressors in patients with intracranial pathologies: a pilot study. J Neurosurg Anesthesiol. 2007;19:257-262.
23. Bourgoin A, Albanese J, Wereszczynski N, et al. Safety of sedation with ketamine in severe head injury patients: comparison with sufentanil. Crit Care Med. 2003;31:711-717.
24. Bourgoin A, Albanese J, Leone M, et al. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med. 2005;33:1109-1113.
25. Rich CL, Smith NT. Anaesthesia for electroconvulsive therapy: a psychiatric viewpoint.Can Anaesth Soc J. 1981;28:153-157.
26. Kranaster L, Kammerer-Ciernioch J, Hoyer C, et al. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Eur Arch Psychiatry Clin Neurosci. 2011;261:575-582.
27. Tokita K, Yamaji T, Hashimoto K. Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacol Biochem Behav. 2012;100:688-704.
28. Koike H, Iijima M, Chaki S. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res. 2011;224:107-111.
29. Loo CK, Katalinic N, Garfield JB, et al. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. J Affect Disord. 2012;142:233-240.
30. McDermott LM, Ebmeier KP. A meta-analysis of depression severity and cognitive function. J Affect Disord. 2009;119:1-8.
31. Lee RSC, Hermens DF, Porter MA, et al. A meta-analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord. 2012;140:113-124.
32. Porter R, Heenan H, Reeves J. Early effects of electroconvulsive therapy on cognitive function. J ECT. 2008;24:35-39.
33. Machado-Vieira R, Salvadore G, Luckenbaugh DA, et al. Rapid onset of antidepressant action: a new paradigm in the research and treatment of major depressive disorder. J Clin Psychiatry. 2008;69:946-958.
34. Abdallah CG, Fasula M, Kelmendi B, et al. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. J ECT. 2012;28:157-161.
35. Wang X, Chen Y, Zhou X, et al. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patientswith depressive disorder. J ECT. 2012;28:128-132.
36. Moy RJ, Le Clerc S. Ketamine in prehospital analgesia and anaesthesia. Trends Anaesthesia Crit Care. 2011;1:243-245.
37. Valentine GW, Mason GF, Gomez R, et al. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [1H]-MRS. Psychiatry Res. 2011;191:122-127.
38. Loo C, Simpson B, MacPherson R. Augmentation strategies in electroconvulsive therapy. J ECT. 2010;26:202-207.